VOYA Investment Management
CUE icon

VOYA Investment Management’s Cue Biopharma CUE Stock Holding History

VOYA Investment Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-448
Closed -$25.4K – 2842
2024
Q1 		$25.4K Sell
448
-37
-8% -$2.61K ﹤0.01% 2776
2023
Q4 		$38.4K Hold
485
– – ﹤0.01% 2872
2023
Q3 		$33.5K Hold
485
– – ﹤0.01% 2883
2023
Q2 		$53.1K Buy
+485
New +$57K ﹤0.01% 2895
2022
Q2 		– Sell
-408
Closed -$60K – 2801
2022
Q1 		$60K Hold
408
– – ﹤0.01% 2577
2021
Q4 		$139K Sell
408
-3
-0.7% -$1.16K ﹤0.01% 2607
2021
Q3 		$180K Hold
411
– – ﹤0.01% 2602
2021
Q2 		$144K Sell
411
-31
-7% -$12K ﹤0.01% 2686
2021
Q1 		$162K Sell
442
-325
-42% -$134K ﹤0.01% 2591
2020
Q4 		$288K Buy
767
+116
+18% +$46.4K ﹤0.01% 2217
2020
Q3 		$294K Buy
651
+325
+100% +$187K ﹤0.01% 1961
2020
Q2 		$239K Sell
326
-24
-7% -$17.4K ﹤0.01% 2066
2020
Q1 		$149K Hold
350
– – ﹤0.01% 2227
2019
Q4 		$167K Buy
+350
New +$110K ﹤0.01% 2431

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

VOYA Investment Management's CUE Position: Q2 2024 in Review

VOYA Investment Management sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 448 shares — an estimated $25.4K sold.

VOYA Investment Management first reported a position in CUE in Q4 2019 and held it in 14 quarters. The position peaked at $294K in Q3 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • VOYA Investment Management reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 448 Cue Biopharma shares in Q2 2024, an estimated $25.4K.
  • VOYA Investment Management first reported a position in Cue Biopharma in Q4 2019 and held it in 14 quarters.
  • VOYA Investment Management's Cue Biopharma position peaked at $294K in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.